About LivaNova
LivaNova is a publicly listed company based in London (United Kingdom) founded in 2015. Therapeutic devices for cardiac and neurological conditions are provided worldwide. The company has 2,900 employees. LivaNova has completed 4 acquisitions, including ALung, Caisson International and ImThera Medical. Its website livanova.com draws about 89 thousand monthly visits. LivaNova offers products and services including Essenzâ„¢ Perfusion System, VNS Therapyâ„¢ for Epilepsy, and VNS Therapyâ„¢ for Depression. Its focus areas include Diversified Medical Devices. Its legal entity is LIVANOVA PLC.
Company details
LivaNova was founded in 2015 and is headquartered in London, United Kingdom. Operations focus on the medical device sector, where cardiac rhythm management and neuromodulation products are developed and distributed. Services include advanced surgical tools and monitoring systems for heart and brain therapies. Global reach is maintained through regulatory compliance and partnerships in healthcare markets, supporting clinical applications across various regions.
- Headquarters London, United Kingdom
- Employees 2,900
- Stage Public
- SectorsHealthcare
- Email••••••••
- Website livanova.com/en-us
- Social LinkedIn Facebook YouTube
- Legal Name Livanova Plc
- Annual Revenue$1.39 B (USD)10.74as on Dec 31, 2025
- Net Profit-$242.47 M (USD)-483.45as on Dec 31, 2025
- EBITDA$284.76 M (USD)31.48as on Dec 31, 2025
- Latest Funding Round$1.23M (USD), Grant
Jan 2021
- InvestorsEuropean Union
& 1 more
- Employee Count2,900
- Investments & AcquisitionsALung
& 3 more
Products & Services of LivaNova
LivaNova offers a comprehensive portfolio of products and services, including Essenz™ Perfusion System, VNS Therapy™ for Epilepsy, and VNS Therapy™ for Depression.
System for supporting cardiopulmonary functions during procedures.
Device that treats drug-resistant epilepsy through nerve stimulation.
Device aimed at managing difficult-to-treat depression via stimulation.
Apps and channels of LivaNova
its YouTube channel LivaNova has 1.24K subscribers and 23 videos.
Videos from LivaNova
The most watched videos on LivaNova's YouTube channel, LivaNova (1.24K subscribers). Click a video to play it here.
More on LivaNova.
Funding Insights of LivaNova
- Total Rounds 6
- Last Round Grant — $1.23M
- First Round $1.76M
(Dec 2014)
- Investors Count 2
All 6 funding rounds of LivaNova with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2021 | $1.23M | Grant | – | – | |
| Apr 2019 | Grant | – | – | ||
| Apr 2019 | Debt – Conventional | – | – | ||
| Jan 2017 | $1.45M | Grant | – | – | |
| Jan 2016 | $499,595 | Grant | – | – | |
| Dec 2014 | $1.76M | Grant | – | – |
2 investors in total: 2 institutional.
Investors in LivaNova
LivaNova has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include European Union and Ministry of Economic Development & Trade.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Timely advice is provided to foreign investors on economic opportunities. | trade.gov.mv | Male, Maldives |
Investor details for LivaNova
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of LivaNova
240 people are tracked at LivaNova (82 in leadership, 7 in board & advisors, 151 in team); the tracked headcount is 2,900.
| Name | Role | Group |
|---|---|---|
Pim Wagnon | Vice President - Treasury, Credit & Risk Management | Leadership |
Rufus Carter | Competitive Intelligence And Data Analytics Director | Leadership |
Michael Hutchinson | SVP, Chief Legal Officer & Company Secretary | Leadership |
Vincenzo Incorvaia | Finance Director - R&d Business Partner | Leadership |
Paolo Paoletti | VP Finance, Cardiopulmonary Business Unit | Leadership |
Alex Shvartsburg | CFO | Leadership |
Stephanie Bolton | President, Global Epilepsy | Leadership |
Liz Fortier | Chief Privacy & Data Governance Officer | Leadership |
Terra Buckley | Chief Compliance Officer | Leadership |
Ben Lang | Director, Global HR Systems & HR PMO | Leadership |
Belle Smith | Operations Director | Leadership |
Cristiano Guglielmi | VP Quality, Cardiopulmonary And International | Leadership |
Dr. Michael Jaeger | Vice President Global Operations Cardiopulmonary | Leadership |
Andrew Briggs | Senior Director - Strategy & Analytics | Leadership |
Francesca D'Ambrosio | Senior Director Operations | Leadership |
Becky P. | Director, International Sales Force Effectiveness/commercial Excellence | Leadership |
Jessica Long | Senior Director | Sustainability ESG │ Global Transformation Owner | Leadership |
William Kozy | Interim CEO & Chair | Leadership |
Kyle Amendola | Vice President Finance | Leadership |
Mirko Prevelato | Sr. Director, Head Of Finance Middle East, Russia And Latin America | Leadership |
220 more people are available in the full profile.
Complete people profiles for LivaNova
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of LivaNova
LivaNova is a publicly listed company on the NASDAQ with ticker symbol LIVN in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date10 Feb 1993
- Listed onNASDAQ: LIVN
- Listed entityLivaNova PLC
- Exchange sectorHealth technology
- ISINGB00BYMT0J19
- Share price$76.37 (-1.16% on the day) · 2026-10-13
- Market capitalisation$4.21B
- Price to earnings22.7
- EPS (diluted, trailing year)$3.37
- Volume (last session)561,290
Financials of LivaNova
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $1.39B | -$242.5M | $284.8M |
| 2024 | $1.25B | $63.2M | $216.6M |
| 2023 | $1.15B | $17.6M | $159.8M |
| 2022 | $1.02B | -$86.2M | $179.5M |
| 2021 | $1.04B | -$135.8M | $131.6M |
Detailed financial statements for LivaNova
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by LivaNova
LivaNova has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include ALung, Caisson International and ImThera Medical.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Extracorporeal CO2 removal systems are developed to supplement mechanical ventilation. | alung.com | Pittsburgh, United States | 1997 | May 2022 | •••• | |
Circulatory support devices and ventricular assist systems are provided. | tandemlife.com | Pittsburgh, United States | 1996 | Feb 2018 | $200M | |
Implantable neurostimulation devices for obstructive sleep apnea are developed. | imtheramedical.com | San Diego, United States | 2008 | Jan 2018 | $225M | |
Outdoor and snow sports apparel and equipment are retailed. | caissonint.com | 0 | May 2017 | •••• |
Complete acquisition details for LivaNova
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of LivaNova
8 dated milestones of LivaNova across 29 years, from founding to its latest funding, stage changes and deals.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $1.8M.
- Founded LivaNova is founded.
- Acquisition Acquires Caisson International.
- Acquisition Acquires ImThera Medical.
- Acquisition Acquires TandemLife.
- Funding Latest funding round, Grant, of $1.2M.
- Acquisition Acquires ALung.
Web traffic of LivaNova
The website of LivaNova (livanova.com) receives about 89.2K visits a month.
- Monthly visits89.2K
▲ 9.2% vs previous month
Websites whose visitors overlap most with LivaNova. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| graylinemedical.com | 100% | #238,989 | View details | ||
| dicardiology.com | 100% | 79.8K | #510,652 | View details | |
| zoll.com | 100% | 191K | #248,728 | View details | |
| getwellue.com | 100% | #228,319 | View details | ||
revmedconnect.com | revmedconnect.com | 100% | #771,336 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 31 similar websites and full traffic analytics for LivaNova
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 31 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Livanova
Complete news archive for LivaNova
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about LivaNova
LivaNova was founded in 2015.
LivaNova is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
LivaNova has 2,900 employees.
Annual revenue of LivaNova is $1.39B as on Dec 31, 2025.
LivaNova was founded in 2015 and is headquartered in London, United Kingdom. Operations focus on the medical device sector, where cardiac rhythm management and neuromodulation products are developed and distributed. Services include advanced surgical tools and monitoring systems for heart and brain therapies. Global reach is maintained through regulatory compliance and partnerships in healthcare markets, supporting clinical applications across various regions.
LivaNova offers Essenzâ„¢ Perfusion System, VNS Therapyâ„¢ for Epilepsy, and VNS Therapyâ„¢ for Depression.
Yes, LivaNova is publicly traded on NASDAQ under the ticker symbol LIVN.
LivaNova has made 4 acquisitions, including ALung, Caisson International, and ImThera Medical.
LivaNova has 2 investors. Key investors include European Union, and Ministry of Economic Development & Trade.
LivaNova operates through Livanova Plc.